Christopher Lemmon

Dr. Christopher Lemmon

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Nature
Verified
Journal Article
Closed access
PDF file
LBLili A. Barouch
Lili A. Barouch
RHRobert W. Harrison
Robert W. Harrison
MSMichel W. Skaf
Michel W. Skaf
GRGisele O. Rosas
Gisele O. Rosas
TCThomas P. Cappola
Thomas P. Cappola
JHJoshua M. Hare
Joshua M. Hare

16 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
CDcaleb dalton
caleb dalton
CLChristopher Lemmon
Christopher Lemmon
The extracellular matrix (ECM) plays a key role as both structural scaffold and regulator of cell signal transduction in tissues. In times of ECM assembly and turnover, cells upregulate assembly of the ECM protein, fibronectin (FN). FN is assembled by cells into viscoelastic fibrils that can bind upward of 40 distinct growth factors and cytokines. These fibrils play a key role in assembling a provisional ECM during embryonic development and wound healing. Fibril assembly is also often upregulated during disease states, including cancer and fibrotic diseases. FN fibrils have unique mechanical properties, which allow them to alter mechanotransduction signals sensed and relayed by cells. Binding of soluble growth factors to FN fibrils alters signal transduction from these proteins, while binding of other ECM proteins, including collagens, elastins, and proteoglycans, to FN fibrils facilitates the maturation and tissue specificity of the ECM. In this review, we will discuss the assembly of FN fibrils from individual FN molecules; the composition, structure, and mechanics of FN fibrils; the interaction of FN fibrils with other ECM proteins and growth factors; the role of FN in transmitting mechanobiology signaling events; and approaches for studying the mechanics of FN fibrils.

1 January 2016 in Biophysical Journal
Verified
Journal Article
Closed access
PAPaul T. Arsenovic
Paul T. Arsenovic
IRIswarya Ramachandran
Iswarya Ramachandran
KBKranthidhar Bathula
Kranthidhar Bathula
RZRuijun Zhu
Ruijun Zhu
JNJiten D. Narang
Jiten D. Narang
DCDaniel Conway
Daniel Conway

19 July 2019 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
LSLewis E. Scott
Lewis E. Scott
SWSeth H. Weinberg
Seth H. Weinberg
CLChristopher Lemmon
Christopher Lemmon
Epithelial-Mesenchymal Transition (EMT) is a critical process in embryonic development in which epithelial cells undergo a transdifferentiation into mesenchymal cells. This process is essential for tissue patterning and organization, and it has also been implicated in a wide array of pathologies. While the intracellular signaling pathways that regulate EMT are well-understood, there is increasing evidence that the mechanical properties and composition of the extracellular matrix (ECM) also play a key role in regulating EMT. In turn, EMT drives changes in the mechanics and composition of the ECM, creating a feedback loop that is tightly regulated in healthy tissues, but is often dysregulated in disease. Here we present a review that summarizes our understanding of how ECM mechanics and composition regulate EMT, and how in turn EMT alters ECM mechanics and composition.

17 July 2006 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DPDana M. Pirone
Dana M. Pirone
WLWendy F. Liu
Wendy F. Liu
SRSami Alom Ruiz
Sami Alom Ruiz
LGLin Gao
Lin Gao
SRSrivatsan Raghavan
Srivatsan Raghavan
CCChristopher S. Chen
Christopher S. Chen
Focal adhesion kinase (FAK) transduces cell adhesion to the extracellular matrix into proliferative signals. We show that FAK overexpression induced proliferation in endothelial cells, which are normally growth arrested by limited adhesion. Interestingly, displacement of FAK from adhesions by using a FAK−/− cell line or by expressing the C-terminal fragment FRNK also caused an escape of adhesion-regulated growth arrest, suggesting dual positive and negative roles for FAK in growth regulation. Expressing kinase-dead FAK-Y397F in FAK−/− cells prevented uncontrolled growth, demonstrating the antiproliferative function of inactive FAK. Unlike FAK overexpression–induced growth, loss of growth control in FAK−/− or FRNK-expressing cells increased RhoA activity, cytoskeletal tension, and focal adhesion formation. ROCK inhibition rescued adhesion-dependent growth control in these cells, and expression of constitutively active RhoA or ROCK dysregulated growth. These findings demonstrate the ability of FAK to suppress and promote growth, and underscore the importance of multiple mechanisms, even from one molecule, to control cell proliferation.

27 October 2006 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SRSungwoo Ryoo
Sungwoo Ryoo
CLChristopher Lemmon
Christopher Lemmon
KSKevin G. Soucy
Kevin G. Soucy
GGGaurav Gupta
Gaurav Gupta
AWAnthony R. White
Anthony R. White
DBDan E. Berkowitz
Dan E. Berkowitz
Oxidized low-density lipoprotein (OxLDL) impairs NO signaling and endothelial function, and contributes to the pathogenesis of atherosclerosis. Arginase reciprocally regulates NO levels in endothelial cells by competing with NO synthase for the substrate l -arginine. In human aortic endothelial cells, OxLDL stimulation increased arginase enzyme activity in a time- and dose-dependent manner. Arginase activity reached its maximum as early as 5 minutes, was maintained for a period of more than 48 hours, and was associated with a reciprocal decrease in NO metabolite (NOx [nitrite and nitrate]) production. Furthermore, OxLDL induced arginase II mRNA expression after 4 hours. Small interfering RNA targeted to arginase II decreased both the quantity and the activity of arginase from baseline, prevented OxLDL-dependent increases in arginase activity, and induced an increase in NOx production. Immunofluorescence analysis revealed an association of arginase II with the microtubule cytoskeleton. Microtubule disruption with nocodazole caused a dramatic redistribution of arginase II to a diffuse cytosolic pattern, increased arginase activity, and decreased NOx production, which was restored in the presence of the specific arginase inhibitor ( S )-(2-boronoethyl)- l -cysteine (BEC). On the other hand, epothilone B prevented microtubule disruption and inhibited OxLDL-dependent increases in arginase activity and attenuated OxLDL-dependent decreases in NOx. Preincubation of rat aortic rings with OxLDL resulted in an increase in arginase activity and a decrease in NOx production. This was reversed by arginase inhibition with the BEC. Thus, OxLDLs increase arginase activity by a sequence of regulatory events that involve early activation through decreased association with microtubules and a later increase in transcription. Furthermore, increased arginase activity contributes to OxLDL-dependent impairment of NOx production. Arginase, therefore, represents a novel target for therapy in atherosclerosis.